Alendronate (ALN), commonly use bisphosphonates is proposed to have osteostimulative properties in vivo and in vitro, as shown by an increase in the matrix formation, and acts as a potent inhibitor of bone resorption. AV widely known for its wound healing, analgesic, antioxidant, antibacterial, antiviral, antifungal, immune boosting and significant anti-inflammatory properties. The present study aims to explore the efficacy of 1% ALN and AV gel as a local drug delivery as an adjunct to scaling and root planing (SRP) for the treatment of degree II furcation defects
Alendronate (ALN), commonly use bisphosphonates is proposed to have osteostimulative properties in vivo and in vitro, as shown by an increase in the matrix formation, and acts as a potent inhibitor of bone resorption. AV widely known for its wound healing, analgesic, antioxidant, antibacterial, antiviral, antifungal, immune boosting and significant anti-inflammatory properties. The present study aims to explore the efficacy of 1% ALN and AV gel as a local drug delivery as an adjunct to scaling and root planing (SRP) for the treatment of degree II furcation defects. Methods: Ninety patients with mandibular buccal class II furcation defects were randomly allocated into three treatment groups: SRP plus placebo gel (group 1), SRP plus 1% ALN gel (group 2) and SRP plus AV gel (group3). Clinical and radiographic parameters were recorded at baseline and gel were delivered at respective site. Then again all clinical and radiographic parameters were recorded after 6 and 12 months from baseline.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
90
Oral prophylaxis followed by placement of placebo gel
Oral prophylaxis followed by placement of Alendronate gel
Oral prophylaxis followed by placement of Aloe Vera gel
Change in Bone defect depth
Assessed in percentage
Time frame: baseline, 6 & 12 months
Change in modified sulcus bleeding index
scale 0-3
Time frame: baseline, 6 & 12 months
Change in Plaque index
scale 0-3
Time frame: baseline, 6 & 12 months
Change in pocket probing depth
measured in mm
Time frame: baseline, 6 & 12 months
Change in relative vertical clinical attachment level
measured in mm
Time frame: baseline, 6 & 12 months
Change in relative horizontal clinical attachment level
measured in mm
Time frame: baseline, 6 & 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.